शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
AHCLNSEAnlon Healthcare Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 6 Mar, 2026 · 13:05 IST

Anlon Healthcare Limited has informed the Exchange that the Board of Directors at its meeting held on March 06, 2026, has considered and approved 1. Sub-division of equity shares from face value of Rs.10/- each to face value of Rs.02/- each., 2. Alteration of Capital Clause of the Memorandum of Association of the Company Subsequent to Sub-Division of Equity Shares, 3. Increase in Authorized Share Capital and Consequent Alteration to the Capital Clause of the Memorandum of Association, 4. Issue of Bonus Shares in the ratio of 1:1.

Stock splitCorporate Actions View source PDFExplain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.2%Reaction day
₹11.13
prior close
₹11.56
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+4.3% vs market
Pharmaceuticals peers, median of 157sector-0.1%+4.3% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 4.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.8
10m
+1.0
15m
+2.7
30m
+1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.2-0.1+4.3-0.1+4.3
Next day
+12.3-2.8+15.1-1.5+13.8
2d
+12.7-0.4+13.1+0.7+12.0
3d
+13.2-0.5+13.8-0.0+13.2
4d
+9.8-0.9+10.6-0.5+10.3
5d
+3.7-3.7+7.4-2.8+6.5
1w
+5.1-3.4+8.5-3.2+8.3
15d
-0.2-7.8+7.6-8.6+8.4
1m
+3.7-1.8+5.5-2.8+6.4
2m
+18.6+15.5+3.1+8.1+10.5
3m
+26.7+14.4+12.3+8.7+18.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anlon Healthcare's board, meeting on March 6, 2026, approved a sub-division (stock split) of equity shares from face value Rs.10 to Rs.2, turning each share into 5 shares. The company will also double its authorized share capital from Rs.55 crore to Rs.110 crore to accommodate further issuances. Additionally, the board approved a bonus issue in a 1:1 ratio, meaning every shareholder will receive one free share for every one held, resulting in roughly 2.66 crore new bonus shares of Rs.2 each. The bonus will be issued from free reserves of about Rs.147 crore available as on December 31, 2025. The record date for both the split and the bonus is yet to be announced, and shareholder approval will be sought via postal ballot.

Likely market impact

The stock split should make shares more affordable and improve liquidity for retail investors, while the 1:1 bonus doubles the number of shares held without any cost — though the share price will adjust downward accordingly. Net wealth remains unchanged for existing shareholders on both actions, but higher share count and lower price typically improve trading activity.